In the increasingly crowded field of regenerative medicine, Organogenesis stands out from the crowd. Not only did the company receive one of the first FDA approvals to market a living, human cell-based product, they’re one of the few companies in the space to successfully transition from clinical innovation to commercial success.
To reinforce their leadership role within the investor community, Organogenesis looked to GrayMatter for a reinvigorated branding campaign that highlighted the company’s ongoing success.
We developed a corporate branding campaign and redesigned corporate website that clearly and convincingly differentiated Organogenesis from other companies in the regenerative medicine space. Based on the positioning The Wonders Of Regenerative Medicine Delivered On A Daily Basis, the campaign made clear that Organogenesis doesn’t merely develop solutions, they’re commercializing them.